CSR Report

The report presents Hanmi Pharm's 2019 sustainability performance under six material topics, highlighting 31 new-drug projects, KRW 209.8 billion consolidated R&D investment and 18.8% R&D-to-revenue. Environmental performance includes a 61% waste recycling rate, 100% recycling of Paltan R/O condensed water, and zero industrial/environmental accidents. The company reports 2,419 employees, 27.9% female staff and 25.0% female executives, alongside a CSR Committee and hEHS Committee. The report is prepared in accordance with GRI Standards Core Option and independently verified by the Korea Standards Association.